ASA Ⅲ级心血管疾病患者口腔种植修复的围手术期风险评估与管理

doi:10.12337/zgkqzzxzz.2024.08.006

中国口腔种植学杂志 ›› 2024, Vol. 29 ›› Issue (4): 328-335.DOI: 10.12337/zgkqzzxzz.2024.08.006

• “全身系统性疾病与牙种植”重点栏目 • 上一篇下一篇

ASA Ⅲ级心血管疾病患者口腔种植修复的围手术期风险评估与管理

张燕婷¹, 汪伟², 陈莉¹, 赵雯¹, 周炜¹

¹口颌系统重建与再生全国重点实验室国家口腔疾病临床医学研究中心陕西省口腔医学重点实验室第四军医大学口腔医院修复科,西安 710032;
²军事口腔医学国家重点实验室口腔疾病国家临床医学研究中心陕西省口腔医学重点实验室第四军医大学口腔医院麻醉科,西安 710032

收稿日期:2024-05-31 出版日期:2024-08-30 发布日期:2024-08-16
通讯作者: 周炜,Email：zhouwei0474@sina.com,电话：029-84776128
作者简介:张燕婷硕士、主治医师,研究方向：口腔种植修复; 周炜, 博士、副主任医师,研究方向：口腔种植修复、口腔美学和显微修复

Perioperative risk assessment and management of oral implant restoration in ASA Ⅲ cardiovascular disease patients

Zhang Yanting¹, Wang Wei², Chen Li¹, Zhao Wen¹, Zhou Wei¹

¹State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Prosthodontics, School of Stomatology, The Fourth Military Medical University, Xi'an 710032, China;
²State Key Laboratory of Military Stomatology and National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Aneshesiology, School of Stomatology, The Fourth Miltary Medical University, Xi'an 710032, China

Received:2024-05-31 Online:2024-08-30 Published:2024-08-16
Contact: Zhou Wei, Email: zhouwei0474@sina.com, Tel: 0086-29-84776128

摘要/Abstract

摘要： 随着口腔种植技术的普及,如何能够安全的为全身复杂系统疾病患者实施种植手术是当下种植医生不得不面临的挑战。根据患者身体状况,美国麻醉医师协会（American Society of Anesthesiologists,ASA）将围手术期风险进行分级,ASAⅠ~Ⅱ级的患者手术风险极低,ASA Ⅳ级以上的患者风险极高,不适合手术。对于ASAⅢ级患者,如何评估围手术期风险、实施种植外科手术、降低围手术期严重并发症是越来越多种植医生关注的问题。本文拟从临床最常见合并心血管疾病的ASA Ⅲ级患者入手,探讨此类患者口腔种植手术的风险评估、防范及并发症防治,为该类患者安全进行种植修复提供参考。

关键词: 口腔种植, 围手术期, 心血管疾病, ASA Ⅲ级

Abstract: With the widespread adoption of implant technology, ensuring the safe implementation of implant surgery for patients with complex systemic diseases has become a challenge that implant dentists must confront. Based on the patient's physical condition, the American Society of Anesthesiologists (ASA) classifies the perioperative risk. Patients at ASA Ⅰ~Ⅱ have an extremely low risk of surgery, while those at ASA Ⅳ and above have a very high risk and are not suitable for surgery. How to assess perioperative risks, perform implant surgery, and reduce serious perioperative complications for ASAⅢ patients is a question that more and more implant doctors are focusing on. This article aims to start with the most common clinical patients with cardiovascular diseases at ASAⅢ, exploring the risk assessment, prevention, complication management of oral implant surgery for such patients, providing a reference for the safe implant restoration for this category of patients.

Key words: Dental implantation, Perioperative period, Cardiovascular diseases, American Society of Anesthesiologists class Ⅲ

张燕婷,汪伟,陈莉,等. ASA Ⅲ级心血管疾病患者口腔种植修复的围手术期风险评估与管理[J]. 中国口腔种植学杂志, 2024, 29(4): 328-335. DOI: 10.12337/zgkqzzxzz.2024.08.006

Zhang Yanting, Wang Wei, Chen Li, Zhao Wen, Zhou Wei. Perioperative risk assessment and management of oral implant restoration in ASA Ⅲ cardiovascular disease patients[J].Chinese Journal of Oral Implantology, 2024, 29(4): 328-335.DOI: 10.12337/zgkqzzxzz.2024.08.006.

参考文献

[1] Masri D, Masri-Iraqi H, Naishlos S, et al.Implant-supported prosthesis is a viable treatment alternative for american society of anesthesiology physical status 3 individuals a retrospective cohort study[J]. J Clin Med, 2022, 11(7):2002. DOI: 10.3390/jcm11072002.
[2] Horvath B, Kloesel B, Todd MM, et al.The evolution, current value, and future of the american society of anesthesiologists physical status classification system[J]. Anesthesiology, 2021, 135(5):904-919. DOI: 10.1097/ALN.0000000000003947.
[3] Miller RD, Eriksson LI, Fleisher LA, et al.Miller's anesthesia[M]. 7th ed. Philadelphia: Churchill Livingstone/Elsevier, 2010.
[4] Irlbeck T, Zwißler B, Bauer A.ASA classification: transition in the course of time and depiction in the literature[J]. Anaesthesist, 2017, 66(1):5-10. DOI: 10.1007/s00101-016-0246-4.
[5] Kearney PM, Whelton M, Reynolds K, et al.Global burden of hypertension: analysis of worldwide data[J]. Lancet, 2005, 365(9455):217-223. DOI: 10.1016/S0140-6736(05)17741-1.
[6] Lu J, Lu Y, Wang X, et al.Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)[J]. Lancet, 2017, 390(10112):2549-2558. DOI: 10.1016/S0140-6736(17)32478-9.
[7] 中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021, 36(6):521-545. DOI: 10.3969/j.issn.1000-3614.2021.06.001.
[8] Kristensen SD, Knuuti J, Saraste A, et al.2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the joint task force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)[J]. Eur Heart J. 2014,35(35):2383-2431. DOI: 10.1093/eurheartj/ehu282.
[9] Wijeysundera DN, Pearse RM, Shulman MA, et al.Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study[J]. Lancet, 2018, 391(10140):2631-2640. DOI: 10.1016/S0140-6736(18)31131-0.
[10] Hartle A, McCormack T, Carlisle J, et al. The measurement of adult blood pressure and management of hypertension before elective surgery: joint guidelines from the Association of Anaesthetists of Great Britain and Ireland and the British Hypertension Society[J]. Anaesthesia, 2016, 71(3):326-337. DOI: 10.1111/anae.13348.
[11] Anisimova EN, Orekhova IV, Sokhov ST, et al.The choice of local anesthesia for patients with hypertension in dental practice[J]. Stomatologiia (Mosk), 2016, 95(1):31-34. DOI: 10.17116/stomat201695131-34.
[12] Chen YJ, Wang YJ.Influence of systemic diseases on the diagnosis and treatment of dental diseases and prevention of related risks[J]. Zhonghua Kou Qiang Yi Xue Za Zhi, 2022, 57(5):474-480. DOI: 10.3760/cma.j.cn112144-20220305-00094.
[13] 丁芳, 杨红霞, 孟焕新. 伴心脑血管疾病患者牙周治疗的风险及防范对策[J]. 中华口腔医学杂志, 2022, 57(6):563-568. DOI: 10.3760/cma.j.cn112144-20220428-00222.
[14] Hawn MT, Graham LA, Richman JS, et al.Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents[J]. JAMA, 2013, 310(14):1462-1472. DOI: 10.1001/jama.2013.278787.
[15] Herman WW, Ferguson HW.Dental care for patients with heart failure: an update[J]. J Am Dent Assoc, 2010, 141(7):845-853. DOI: 10.14219/jada.archive.2010.0282.
[16] Lyons WL.Approach to evaluating the multimorbid patient with cardiovascular disease undergoing noncardiac surgery[J]. Clin Geriatr Med, 2016, 32(2):347-358. DOI: 10.1016/j.cger.2016.01.007.
[17] 中华口腔医学会镇静镇痛专业委员会.非麻醉医师实施口腔诊疗适度镇静/镇痛专家共识: T/CHSA 003-2023[S].北京:中华口腔医学会,2023.
[18] 黄志权,张大明.微创外科技术在口腔颌面外科中的应用[J].口腔疾病防治,2018,26(2):75-82. DOI: 10.12016/j.issn.2096-1456.2018.02.002.
[19] Chatterjee A, Hage FG.Guidelines in review: 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines[J]. J Nucl Cardiol, 2015, 22(1):158-161. DOI: 10.1007/s12350-014-9992-3.
[20] Serrera Figallo MA, Velázquez Cayón RT, Torres Lagares D, et al.Use of anesthetics associated to vasoconstrictors for dentistry in patients with cardiopathies. Review of the literature published in the last decade[J]. J Clin Exp Dent, 2012, 4(2):e107-e111. DOI: 10.4317/jced.50590.
[21] 中华医学会麻醉学分会, 麻醉后监测治疗专家共识[J]. 临床麻醉学杂志, 2021, 37(1):89-94. DOI:10.12089/jca.2021.01.020
[22] Han Chong,He Dongning,Yu Feiyan,et al.Research progress on the mechanism and treatment of pain after oral implants[J]. Int J Stomatol, 2024, 51(1): 99-106. DOI:10.7518/gjkq. 2024002.
[23] 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中华医学会心血管病学分会介入心脏病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. 冠心病双联抗血小板治疗中国专家共识[J]. 中华心血管病杂志, 2021, 49(5):432-454. DOI: 10.3760/cma.j.cn112148-20210125-00088.
[24] Valgimigli M, Bueno H, Byrne RA, et al.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)[J]. Eur Heart J, 2018, 39(3):213-260. DOI: 10.1093/eurheartj/ehx419.
[25] Chaushu L, Perez N, Botticelli D, et al.The effect of anticoagulants on early implant failure: a retrospective cohort study[J]. J Funct Biomater, 2023, 14(4):186. DOI: 10.3390/jfb14040186.
[26] Conrad HJ, Jung J, Barczak M, et al.Retrospective cohort study of the predictors of implant failure in the posterior maxilla[J]. Int J Oral Maxillofac Implants, 2011, 26(1):154-162.
[27] Zinser MJ, Randelzhofer P, Kuiper L, et al.The predictors of implant failure after maxillary sinus floor augmentation and reconstruction: a retrospective study of 1045 consecutive implants[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 115(5):571-582. DOI: 10.1016/j.oooo.2012.06.015.
[28] D'Ambrosio F, Amato A, Chiacchio A, et al. Do systemic diseases and medications influence dental implant osseointegration and dental implant health? An umbrella review[J]. Dent J (Basel), 2023, 11(6):146. DOI: 10.3390/dj11060146.
[29] Schimmel M, Srinivasan M, McKenna G, et al. Effect of advanced age and/or systemic medical conditions on dental implant survival: a systematic review and meta-analysis[J]. Clin Oral Implants Res, 2018, 29(Suppl 16):311-330. DOI: 10.1111/clr.13288.

ASA Ⅲ级心血管疾病患者口腔种植修复的围手术期风险评估与管理

Perioperative risk assessment and management of oral implant restoration in ASA Ⅲ cardiovascular disease patients

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	汤祎熳, 邱立新. 器官移植患者接受种植治疗时的临床思考[J]. 中国口腔种植学杂志, 2024, 29(4): 297-302.
[2]	赵国强, 宋应亮. 2型糖尿病个体进行即刻种植即刻修复预后的动物实验研究[J]. 中国口腔种植学杂志, 2024, 29(4): 311-319.
[3]	邱韵, 王宇蓝, 张玉峰. 骨质疏松症对牙种植的影响及临床考量[J]. 中国口腔种植学杂志, 2024, 29(4): 336-341.
[4]	王一茗, 李昕茹, 滕微微, 马骏驰, 周立波. 口腔种植机器人在临床前及临床研究应用精度的Meta分析[J]. 中国口腔种植学杂志, 2024, 29(4): 362-370.
[5]	李歆, 刘开政, 武诗语, 刘远翔, 黄宝鑫, 乔威, 潘浩波, 陈卓凡. 口腔种植治疗中骨再生材料的研究现状[J]. 中国口腔种植学杂志, 2024, 29(4): 371-377.
[6]	陈江, 丘雨蓓. 数字化技术在口腔种植骨增量中的应用及研究进展[J]. 中国口腔种植学杂志, 2024, 29(3): 252-257.
[7]	王铭阳, 黄海涛. 质子泵抑制剂对口腔种植体骨结合影响的研究进展[J]. 中国口腔种植学杂志, 2024, 29(3): 277-283.
[8]	王琦, 杨波, 刘璐, 李翠英, 王心彧. 不同颌骨密度下种植体设计对其骨界面应力分布影响的有限元分析[J]. 中国口腔种植学杂志, 2024, 29(2): 159-168.
[9]	宣岩, 郝俊燕, 安阳, 张婷, 张文静, 李丹. 基于“互联网+”健康管理模式在口腔种植患者围手术期的应用[J]. 中国口腔种植学杂志, 2024, 29(1): 56-61.
[10]	孟怡麟, 瞿晓辉, 滕新亚, 李如华, 毕立锋, 邹德荣. 全牙列即刻种植即刻负荷的机器人复杂种植[J]. 中国口腔种植学杂志, 2024, 29(1): 70-76.
[11]	高乾程, 李新东, 曹明国, 刘云峰. 基于CBCT的深度学习辅助解剖结构分割在口腔种植中的应用[J]. 中国口腔种植学杂志, 2024, 29(1): 82-86.
[12]	徐淑兰, 朱元希. 种植体周炎的治疗决策和预后评估[J]. 中国口腔种植学杂志, 2023, 28(6): 394-401.
[13]	宋嘉颖, 陈卓凡, 黄宝鑫. 种植修复患者随访维护依从性及影响因素：现状与展望[J]. 中国口腔种植学杂志, 2023, 28(6): 430-436.
[14]	陈金妍, 张筠, 吴轶群, 王凤. 虚拟患者构建在口腔种植中应用的现状[J]. 中国口腔种植学杂志, 2023, 28(6): 473-477.
[15]	孙晓琳, 刘佳, 周延民, 王林, 李春艳, 阿兰, 付丽. 口腔种植学线上线下混合式教学模式的探索[J]. 中国口腔种植学杂志, 2023, 28(6): 478-482.